Research-Article
You have full text access to this OnlineOpen article
Long-Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone Density
Article first published online: 1 AUG 1997
DOI: 10.1359/jbmr.1997.12.8.1314
Copyright © 1997 ASBMR
Additional Information
How to Cite
Weinstein, R. S. (1997), Long-Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone Density. J Bone Miner Res, 12: 1314–1315. doi: 10.1359/jbmr.1997.12.8.1314
Publication History
- Issue published online: 4 DEC 2009
- Article first published online: 1 AUG 1997
REFERENCES
- 1, , , , , 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome N Engl J Med 325:1688–1695; 1738-1740 (editorial).
- 2, , , 1994 An activating Gsα mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome J Clin Endocrinol Metab 79:750–755.
- 3, , , , , , , , , , 1996 Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome J Clin Invest 98:30–35.
- 4, , , 1995 Increased expression of the c-fos proto-oncogene in bone marrow from patients with fibrous dysplasia N Engl J Med 352:1546–1551.
- 5, , , , , 1988 Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome) N Engl J Med 319:421–425.
- 6, , 1994 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone Lancet 343:953–954.

1523-4681/asset/olbannerleft.gif?v=1&s=d7e4c0e37904a489128d3a4e58ba94214db307a9)
1523-4681/asset/olbannerright.gif?v=1&s=854ee0e4d351ead9faaca8bfab3e50b1c7c9d03d)
1523-4681/asset/cover.gif?v=1&s=a8419ff5f302b0d9fefec557d81c0aa9776c60e3)